Effect of ultraviolet irradiation on the antitumor activity of bleomycin

H Mori1

  • 1Laboratory of Theoretical and Molecular Biology, Faculty of Pharmaceutical Sciences, Kumamoto University, Japan.

Insights

Bleomycin (BLM) shows antitumor effects against melanoma, enhanced by UV irradiation. However, catechol pretreatment reduces UV-irradiated BLM

Area of Science:

  • Oncology
  • Biochemistry
  • Pharmacology

Background:

  • Bleomycin (BLM) is a chemotherapy agent used to treat various cancers.
  • The chorioallantoic membrane (CAM) of chick embryos provides a model for studying tumor growth and anti-cancer drug efficacy.
  • Understanding drug interactions and modifications is crucial for optimizing cancer therapy.

Purpose of the Study:

  • To investigate the combined effect of bleomycin (BLM) and ultraviolet (UV) irradiation on the growth of murine B16 melanoma in a chick embryo model.
  • To evaluate the impact of catechol pretreatment on the efficacy of UV-irradiated BLM.
  • To assess the direct cytotoxicity of BLM and UV-irradiated BLM on cultured melanoma cells.

Main Methods:

  • Murine B16 melanoma cells were implanted onto the chorioallantoic membrane of chick embryos.
  • Tumor growth inhibition was measured after treatment with BLM, UV-irradiated BLM, and BLM pretreated with catechol.
  • Direct cytotoxicity assays were performed on cultured B16 melanoma cells.

Main Results:

  • Bleomycin (BLM) inhibited tumor growth by approximately 30% at a dose of 3 micrograms/egg.
  • UV irradiation enhanced the antitumor activity of BLM, with inhibition ratios of about 50% after 10 minutes of irradiation.
  • Catechol pretreatment significantly reduced the antitumor activity of UV-irradiated BLM, and also decreased the direct cytotoxicity of BLM to melanoma cells.

Conclusions:

  • UV irradiation can enhance the in vivo antitumor activity of bleomycin (BLM).
  • Catechol inhibits the activity of UV-irradiated BLM, both in vivo and in vitro.
  • These findings suggest a potential method for the in vivo activation of BLM, with implications for cancer treatment strategies.